Skip to main content

Table 5 Immunohistochemical characteristics

From: Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases

Patient Number

BRAF status

CK7

AMACR

WT-1

CD57

P53

BCL2

CCND1

P16

p-ERK

ERK

p-MEK

MEK

DUSP6

1

BRAF V600E

3+

2+

3+

3+

3+

2+

3+

2+

2

BRAF wild-type

3+

3+

2+

3+

2+

3+

1+

3

BRAF V600E

1+

2+

1+

2+

1+

2+

1+

4

BRAF wild-type

2+

2+

1+

2+

1+

3+

5

BRAF V600E

3+

3+

1+

3+

2+

3+

1+

6

BRAF V600E

3+

2+

1+

2+

1+

2+

1+

7

BRAF V600E

1+

2+

2+

2+

1+

1+

1+

2+

1+

8

BRAF V600E

2+

2+

2+

2+

2+

1+

3+

9

BRAF V600E

3+

3+

3+

2+

1+

2+

1+

3+

1+

10

BRAF V600E

1+

3+

2+

2+

1+

1+

1+

3+

2+

11

BRAF V600E

3+

2+

3+

3+

1+

2+

1+

2+

2+

12

BRAF V600E

3+

3+

3+

2+

2+

1+

2+

13

BRAF V600E

2+

3+

2+

1+

1+

1+

2+

1+

14

BRAF V600E

3+

2+

 

2+

1+

1+

1+

1+

2+

1+

15

BRAF V600E

1+

3+

1+

2+

2+

1+

2+

16

BRAF V600E

1+

1+

2+

1+

1+

2+

3+

17

BRAF wild-type

1+

1+

1+

2+

1+

3+

1+

18

BRAF V600E

1+

1+

3+

3+

3+

1+

3+

1+

19

BRAF V600E

1+

3+

2+

3+

1+

1+

2+

20

BRAF Intron8-STARD9/ CUX1/ LOC100507389 fusion

+/−

1+

1+

3+

3+

1+

2+

1+

2+

1+

21

BRAF V600E

1+

1+

2+

1+

1+

1+

3+

1+

22

BRAF V600E

1+

1+

3+

1+

1

1+

1+

2+

1+

23

BRAF V600E

+/−

1+

1+

1+

3+

2+

1

1+

1+

2+

1+

24

BRAF wild-type

1+

1+

2+

1+

2+

1+

1+

1+

25

BRAF wild-type

1+

1+

3+

1+

3+

2+

2+

26

BRAF V600E

1+

1+

3+

1+

3+

1+

3+

2+

27

BRAF V600E

1+

1+

2+

2+

1+

1+

3+

1+

28

BRAF V600E

1+

1+

3+

1+

1+

1+

1+

1+

1+